Skip to content
Back to announcement

20260707_SDPC_Pengumuman RUPS_32109056_lamp1.pdf

RUPS notice Text extracted SDPC

Source file signed link, expires in 15 minutes

This browser can't display the PDF inline. Open it in a new tab.

Extracted text 1

Page 1 OCR 0.916
MPI

PT MILLENNIUM PHARMACON INTERNATIONAL Tbk

Jakarta, 07 Juli 2026

No. : 424/MPI/DIR/VII/2026
Lamp. : 2 (dua) lembar

Kepada Yth.

Otoritas Jasa Keuangan

Gedung Sumitro Djojohadikusumo
Jl. Lapangan Banteng Timur No. 2-4
Jakarta 10710

Up : Bapak Hasan Fawzi — Kepala Eksekutif Pengawas Pasar Modal

Perihal ': Pengumuman Rapat Umum Pemegang Saham Luar Biasa PT Millennium
Pharmacon International Tbk
Announcement of Extraordinary General Meeting of Shareholders PT Millennium
Pharmacon International Tbk

Dengan hormat,

Untuk memenuhi ketentuan yang terdapat dalam Pasal 14 dan Pasal 52 ayat (1) Peraturan Otoritas Jasa
Keuangan (POJK) Nomor 15/POJK.04/2020 tentang Rencana dan Penyelenggaraan Rapat Umum
Pemegang Saham Perusahaan Terbuka, dengan ini kami, PT Millennium Pharmacon International Tbk
(“Perseroan”) menyampaikan Pengumuman Rapat Umum Pemegang Saham Luar Biasa (“RUPSLB”)
yangakan diselenggarakanpada tanggal 13 Agustus 2026, yangmana pengumuman ini akan dipublikasikan
di website penyedia e-RUPS (PT Kustodian Sentral Efek Indonesia), web Bursa Efek Indonesia, dan
website Perseroan.

Dear Sir/Madam,

To comply with the provisions of Article 14 and Article 52 paragraph (1) of Financial Services Authority
Regulation (POJK) No. 15/POJK.04/2020 regarding the Planning and Organization of General Meetings
of Shareholders of Public Companies, PT Millennium Pharmacon International Tbk (the “Company”)
hereby announces the Extraordinary General Meeting of Shareholders (“EGMS”), whichwill be convened
on August 13, 2026. This announcement will be made available through the website of the e-GMS provider
(PT KustodianSentral Efek Indonesia), the Indonesia StockExchange website, and the Company 's website.

Hormat kami,
PT Millennium Pharmacon International Tbk

(PT. MLLEMMYUN PHARMACON Tok
Dr. Imam Fathorrahman, M.M.
Direktur Utama / President Director

Tembusan/CC:
1. Kepala Divisi Penilaian Perusahaan 3 PT Bursa Efek Jakarta.
2. PT Kustodian Sentral Efek Indonesia.

Crown Bungur Arteri 2-4th Floors
Jl. Sultan Iskandar Muda No. 18, Jakarta 12240, Indonesia
Phone : #6221 27085961

File

File Open PDF
Source IDX
Size0.39 MB
Published7 Jul 2026
Pages1
Characters2,108
Text sourceOCR
OCR confidence0.916

Names mentioned 10 people and organisations named in the text · linked when the evidence is strong

linked person Dr. Imam Fathorrahman · Direktur Utama / President Director p.1
possible org Otoritas Jasa Keuangan p.1 ×2
possible person Hasan Fawzi p.1
possible org Bursa Efek Indonesia p.1
unresolved org PT Kustodian Sentral Efek Indonesia p.1 ×2
unresolved org Financial Services Authority p.1
unresolved org PT KustodianSentral Efek Indonesia p.1
unresolved org PT. MLLEMMYUN PHARMACON Tok Dr. Imam Fathorrahman p.1
unresolved org PT Kustodian Sentral Efek Indonesia. Crown Bungur Arteri p.1

Extraction attempts how the parser did, and what it refused

Nothing structured was extracted from this document — the attempts below say why.

No extraction attempted yet.

↑↓ select ↵ open ⇧↵ see every result